[{"address1": "535 W 24th Street", "address2": "5th Floor", "city": "New York", "state": "NY", "zip": "10011", "country": "United States", "phone": "(855) 508-3568", "website": "https://www.neurogene.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Neurogene Inc., a biotechnology company, develops genetic medicines for rare neurological diseases. The company's product candidates include NGN-401 which is packaged in an adeno-associated virus 9 that is in Phase 1/2 clinical trial for the treatment of Rett syndrome; and NGN-101, a conventional gene therapy candidate that is in Phase 1/2 clinical trial to treat CLN5 Batten disease. It has a license agreement with The University of North Carolina, the University of Edinburgh, Virovek, Inc., and Sigma-Aldrich Co. LLC. The company is headquartered in New York, New York.", "fullTimeEmployees": 91, "companyOfficers": [{"maxAge": 1, "name": "Dr. Rachel L. McMinn Ph.D.", "age": 50, "title": "Founder, Executive Chair & CEO", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 676542, "exercisedValue": 0, "unexercisedValue": 203486}, {"maxAge": 1, "name": "Ms. Christine Mikail Cvijic J.D.", "age": 45, "title": "President, CFO & Corporate Secretary", "yearBorn": 1978, "fiscalYear": 2023, "totalPay": 623289, "exercisedValue": 0, "unexercisedValue": 658819}, {"maxAge": 1, "name": "Dr. Stuart  Cobb Ph.D.", "age": 53, "title": "Chief Scientific Officer", "yearBorn": 1970, "fiscalYear": 2023, "totalPay": 478807, "exercisedValue": 0, "unexercisedValue": 338906}, {"maxAge": 1, "name": "Mr. Arvind  Sreedharan", "title": "Senior Vice President of Business Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Donna M. Cochener-Metcalfe J.D.", "age": 48, "title": "Senior VP & General Counsel", "yearBorn": 1975, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Effie  Albanis M.D.", "title": "Senior Vice President of Early Clinical & Translational Research", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Andrew E. Mulberg CPI, FAAP, M.D.", "title": "Senior Vice President of Regulatory Affairs, Quality Assurance & Quality Control", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ricardo  Jimenez", "title": "Senior Vice President of Technical Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Julie  Jordan M.D.", "age": 51, "title": "Chief Medical Officer", "yearBorn": 1972, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 5, "boardRisk": 7, "compensationRisk": 7, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1725148800, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 42.76, "open": 42.325, "dayLow": 38.18, "dayHigh": 44.0, "regularMarketPreviousClose": 42.76, "regularMarketOpen": 42.325, "regularMarketDayLow": 38.18, "regularMarketDayHigh": 44.0, "forwardPE": -8.968821, "volume": 106843, "regularMarketVolume": 106843, "averageVolume": 133087, "averageVolume10days": 92960, "averageDailyVolume10Day": 92960, "bid": 40.26, "ask": 40.96, "bidSize": 100, "askSize": 100, "marketCap": 523252288, "fiftyTwoWeekLow": 12.49, "fiftyTwoWeekHigh": 53.0, "priceToSalesTrailing12Months": 565.67816, "fiftyDayAverage": 38.4944, "twoHundredDayAverage": 33.268475, "currency": "USD", "enterpriseValue": 415486880, "floatShares": 5076605, "sharesOutstanding": 12993600, "sharesShort": 1821180, "sharesShortPriorMonth": 1556928, "sharesShortPreviousMonthDate": 1722384000, "dateShortInterest": 1724976000, "sharesPercentSharesOut": 0.1402, "heldPercentInsiders": 0.10694, "heldPercentInstitutions": 1.0242, "shortRatio": 20.1, "shortPercentOfFloat": 0.1568, "bookValue": 11.934, "priceToBook": 3.3743925, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": 2364000, "trailingEps": -3.66, "forwardEps": -4.49, "pegRatio": -0.36, "enterpriseToRevenue": 449.175, "enterpriseToEbitda": -6.347, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "NGNE", "underlyingSymbol": "NGNE", "shortName": "Neurogene Inc.", "longName": "Neurogene Inc.", "firstTradeDateEpochUtc": 1394202600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "51d6a4c2-efb6-34ae-b4ed-f6ab994594b8", "gmtOffSetMilliseconds": -14400000, "currentPrice": 40.27, "targetHighPrice": 65.0, "targetLowPrice": 44.0, "targetMeanPrice": 51.4, "targetMedianPrice": 49.0, "recommendationMean": 1.4, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 5, "totalCash": 153904992, "totalCashPerShare": 11.845, "ebitda": -65467000, "totalDebt": 13785000, "quickRatio": 11.822, "currentRatio": 12.174, "totalRevenue": 925000, "debtToEquity": 8.893, "revenuePerShare": 0.106, "returnOnAssets": -0.32361, "returnOnEquity": -0.41339, "freeCashflow": -34067876, "operatingCashflow": -66083000, "operatingMargins": -21.766489, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-09-17"}]